References
- Søgaard M, Nielsen RB, Nørgaard M, Kornum JB, Schønheyder HC, Thomsen RW. Incidence, length of stay, and prognosis of hospitalized patients with pleural empyema: a 15-year Danish nationwide cohort study. Chest. 2014;145(1):189–192.
- Davies HE, Davies RJ, Davies CW; Group BTSPDG. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax. 2010;65l 2:ii41–ii53.
- Rosenstengel A. Pleural infection-current diagnosis and management. J Thorac Dis. 2012;4(2):186–193.
- Rahman NM, Maskell NA, West A, et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med. 2011;365(6):518–526.
- Koppurapu V, Meena N. A review of the management of complex para-pneumonic effusion in adults. J Thorac Dis. 2017;9(7):2135–2141.
- Mehta HJ, Biswas A, Penley AM, Cope J, Barnes M, Jantz MA. Management of Intrapleural Sepsis with Once Daily Use of Tissue Plasminogen Activator and Deoxyribonuclease. Respiration. 2016;91(2):101–106.
- Majid A, Kheir F, Folch A, et al. Concurrent intrapleural instillation of tissue plasminogen activator and DNase for pleural infection. A single-center experience. Annals ATS. 2016;13(9):1512–1518.
- Bishwakarma R, Shah S, Frank L, Zhang W, Sharma G, Nishi SP. Mixing it up: Coadministration of tPA/DNase in complicated parapneumonic pleural effusions and empyema. J Bronchology Interv Pulmonol. 2017;24(1):40–47.
- Popowicz N, Bintcliffe O, De Fonseka D, et al. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The Alteplase Dose Assessment for Pleural Infection Therapy Project. Annals ATS. 2017;14(6):929–936.
- McClune JR, Wilshire CL, Gorden JA, et al. Safety and efficacy of Intrapleural Tissue Plasminogen Activator and DNase during extended use in complicated pleural space infections. Can Respir J. 2016;2016:1.
- Piccolo F, Pitman N, Bhatnagar R, et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Annals ATS. 2014;11(9):1419–1425.
- Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest. 2014;145(4):848–855.
- Porcel JM. Minimally invasive treatment of complicated parapneumonic effusions and empyemas in adults. Clin Respir J. 2018;12(4):1361–1366.
- Rahman NM, Maskell NA, Davies CW, et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest. 2010;137(3):536–543.